应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AVTX Avalo Therapeutics Inc
盘前交易 11-18 04:17:30 EST
7.13
-0.24
-3.26%
最高
7.57
最低
6.88
成交量
313.37万
今开
7.57
昨收
7.37
日振幅
9.36%
总市值
4.12亿
流通市值
2.85亿
总股本
5,782万
成交额
2,211万
换手率
7.84%
流通股本
3,998万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Leerink Partners首次覆盖Avalo Therapeutics,给予“跑赢大盘”评级,目标价38美元
美股速递 · 07-06
Leerink Partners首次覆盖Avalo Therapeutics,给予“跑赢大盘”评级,目标价38美元
Avalo Therapeutics扩充管线,引入长效新一代抗IL-1β抗体AVTX-010
美股速递 · 06-16
Avalo Therapeutics扩充管线,引入长效新一代抗IL-1β抗体AVTX-010
美银全球研究首次覆盖Avalo Therapeutics,给予买入评级及35美元目标价
美股速递 · 06-12
美银全球研究首次覆盖Avalo Therapeutics,给予买入评级及35美元目标价
异动解读 | 分析师下调目标价,Avalo Therapeutics盘中大跌5.11%
异动解读 · 05-15
异动解读 | 分析师下调目标价,Avalo Therapeutics盘中大跌5.11%
Avalo Therapeutics 现有现金及等价物与短期投资预计可支持运营至2029年
美股速递 · 05-13
Avalo Therapeutics 现有现金及等价物与短期投资预计可支持运营至2029年
Avalo Therapeutics, Inc.盘中异动 快速上涨6.19%报8.24美元
市场透视 · 2025-03-11
Avalo Therapeutics, Inc.盘中异动 快速上涨6.19%报8.24美元
Avalo Therapeutics, Inc.盘中异动 下午盘急速拉升5.44%报7.36美元
市场透视 · 2025-03-07
Avalo Therapeutics, Inc.盘中异动 下午盘急速拉升5.44%报7.36美元
Avalo Therapeutics, Inc.盘中异动 股价大涨6.71%
市场透视 · 2025-03-05
Avalo Therapeutics, Inc.盘中异动 股价大涨6.71%
Avalo Therapeutics, Inc.盘中异动 早盘股价大跌5.61%报6.90美元
市场透视 · 2025-03-03
Avalo Therapeutics, Inc.盘中异动 早盘股价大跌5.61%报6.90美元
Avalo Therapeutics, Inc.盘中异动 早盘股价大涨5.61%报6.97美元
市场透视 · 2025-02-28
Avalo Therapeutics, Inc.盘中异动 早盘股价大涨5.61%报6.97美元
Avalo Therapeutics, Inc.盘中异动 快速跳水5.10%报6.88美元
市场透视 · 2025-02-27
Avalo Therapeutics, Inc.盘中异动 快速跳水5.10%报6.88美元
Avalo Therapeutics, Inc.盘中异动 急速下挫6.17%
市场透视 · 2025-02-25
Avalo Therapeutics, Inc.盘中异动 急速下挫6.17%
Avalo Therapeutics, Inc.盘中异动 早盘股价大涨6.04%报8.95美元
市场透视 · 2025-02-24
Avalo Therapeutics, Inc.盘中异动 早盘股价大涨6.04%报8.95美元
Avalo Therapeutics, Inc.股价上涨10.82% 市值涨901.49万美元
市场透视 · 2025-02-21
Avalo Therapeutics, Inc.股价上涨10.82% 市值涨901.49万美元
Avalo Therapeutics, Inc.盘中异动 下午盘快速跳水5.30%报7.32美元
市场透视 · 2025-02-15
Avalo Therapeutics, Inc.盘中异动 下午盘快速跳水5.30%报7.32美元
Avalo Therapeutics, Inc.盘中异动 早盘股价大涨5.36%
市场透视 · 2025-02-05
Avalo Therapeutics, Inc.盘中异动 早盘股价大涨5.36%
Avalo Therapeutics, Inc.盘中异动 快速下跌6.24%报7.90美元
市场透视 · 2025-02-03
Avalo Therapeutics, Inc.盘中异动 快速下跌6.24%报7.90美元
Avalo Therapeutics, Inc.盘中异动 急速拉升5.79%报8.04美元
市场透视 · 2025-01-30
Avalo Therapeutics, Inc.盘中异动 急速拉升5.79%报8.04美元
Avalo Therapeutics, Inc.盘中异动 股价大涨7.82%报7.72美元
市场透视 · 2025-01-29
Avalo Therapeutics, Inc.盘中异动 股价大涨7.82%报7.72美元
Avalo Therapeutics, Inc.盘中异动 快速上涨5.52%报7.96美元
市场透视 · 2025-01-27
Avalo Therapeutics, Inc.盘中异动 快速上涨5.52%报7.96美元
加载更多
公司概况
公司名称:
Avalo Therapeutics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Avalo Therapeutics, Inc.于2011年1月31日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,完全致力于开发基于IL-1β的免疫介导的炎症性疾病治疗方法。公司的主要候选产品abdakibart(AVTX-009),一种抗IL-1β单抗(“MAB”),正处于化脓性汗腺炎(“HS”)的2期临床试验中。该公司还在探索更多机会,以在存在大量未满足需求的流行适应症方面产生影响。
发行价格:
--
{"stockData":{"symbol":"AVTX","market":"US","secType":"STK","nameCN":"Avalo Therapeutics Inc","latestPrice":7.13,"timestamp":1794949200000,"preClose":7.37,"halted":0,"volume":3133699,"delay":0,"changeRate":-0.03256445047489826,"floatShares":39984700,"shares":57823083,"eps":-2.9068,"marketStatus":"盘前交易","change":-0.24,"latestTime":"11-18 04:17:30 EST","open":7.57,"high":7.57,"low":6.88,"amount":22105979.2137735,"amplitude":0.093623,"askPrice":8.14,"askSize":100,"bidPrice":6.41,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.9068,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795012200000},"marketStatusCode":1,"adr":0,"listingDate":1447390800000,"exchange":"NASDAQ","adjPreClose":7.13,"postHourTrading":{"tag":"盘后","latestPrice":7.13,"preClose":7.13,"latestTime":"19:55 EST","volume":28369,"amount":197176.76,"timestamp":1794963334178,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.403517611499895,"impliedVol":1.313,"impliedVolPercentile":0.728},"requestUrl":"/m/hq/s/AVTX","defaultTab":"news","newsList":[{"id":"1151106505","title":"Leerink Partners首次覆盖Avalo Therapeutics,给予“跑赢大盘”评级,目标价38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1151106505","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151106505?lang=zh_cn&edition=full","pubTime":"2026-07-06 18:55","pubTimestamp":1783335313,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners日前宣布,正式启动对生物制药公司Avalo Therapeutics Inc.的研究覆盖,并给予其股票“跑赢大盘”的评级。分析师为该股设定的目标价格为每股38美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188200472","title":"Avalo Therapeutics扩充管线,引入长效新一代抗IL-1β抗体AVTX-010","url":"https://stock-news.laohu8.com/highlight/detail?id=1188200472","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188200472?lang=zh_cn&edition=full","pubTime":"2026-06-16 19:06","pubTimestamp":1781607986,"startTime":"0","endTime":"0","summary":"Avalo Therapeutics公司宣布其研发管线迎来新成员——AVTX-010。这是一款长效的新一代抗白细胞介素-1β(IL-1β)抗体,旨在为相关疾病领域提供创新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169747777","title":"美银全球研究首次覆盖Avalo Therapeutics,给予买入评级及35美元目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1169747777","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169747777?lang=zh_cn&edition=full","pubTime":"2026-06-12 18:18","pubTimestamp":1781259493,"startTime":"0","endTime":"0","summary":"美银全球研究(BofA Global Research)宣布,对生物技术公司Avalo Therapeutics Inc启动研究覆盖,并给予其股票“买入”评级。该机构同时设定了35美元的目标股价,预示着对公司未来前景的积极展望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117683293","title":"异动解读 | 分析师下调目标价,Avalo Therapeutics盘中大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117683293","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117683293?lang=zh_cn&edition=full","pubTime":"2026-05-15 03:53","pubTimestamp":1778788388,"startTime":"0","endTime":"0","summary":"Avalo Therapeutics Inc(AVTX)今日盘中股价大幅下挫5.11%,引起了投资者的关注。消息面上,多家华尔街投行在今日发布了针对该公司的研究报告并调整了其目标价,其中H.C. Wainwright将目标价从40美元下调至35美元,Wedbush将目标价从40美元下调至34美元,这两项关键的下调操作可能影响了市场信心,成为股价下跌的主要压力。尽管瑞穗证券将目标价从39美元上调至45美元,但整体上分析师意见出现分歧,且下调目标价的行动对市场情绪产生了更直接的影响,导致该股在交易时段内承压走低。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193194536","title":"Avalo Therapeutics 现有现金及等价物与短期投资预计可支持运营至2029年","url":"https://stock-news.laohu8.com/highlight/detail?id=1193194536","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193194536?lang=zh_cn&edition=full","pubTime":"2026-05-13 19:08","pubTimestamp":1778670499,"startTime":"0","endTime":"0","summary":"根据公司披露的财务信息,Avalo Therapeutics Inc. 目前的现金、现金等价物以及短期投资总额,预计足以支持其日常运营及研发活动持续进行至2029年。这一充裕的财务缓冲为公司推进其临床阶段项目提供了关键的资金保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518203857","title":"Avalo Therapeutics, Inc.盘中异动 快速上涨6.19%报8.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518203857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518203857?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:20","pubTimestamp":1741623628,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时20分,Avalo Therapeutics, Inc.股票出现异动,股价快速拉升6.19%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃,换手率分别为3705.04%、3188.84%、944.79%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.,振幅分别为88.14%、78.32%、49.87%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002028abf33936&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002028abf33936&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517194347","title":"Avalo Therapeutics, Inc.盘中异动 下午盘急速拉升5.44%报7.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517194347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517194347?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:17","pubTimestamp":1741288628,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时17分,Avalo Therapeutics, Inc.股票出现异动,股价快速拉升5.44%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.71%。其相关个股中,Plus Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为5013.44%、3925.30%、257.97%,振幅较大的相关个股有Plus Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Tonix Pharmaceuticals Holding Corp.,振幅分别为133.94%、125.28%、71.44%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307031709963c7e4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307031709963c7e4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517279985","title":"Avalo Therapeutics, Inc.盘中异动 股价大涨6.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517279985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517279985?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:23","pubTimestamp":1741119819,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时23分,Avalo Therapeutics, Inc.股票出现异动,股价急速上涨6.71%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.27%。其相关个股中,Rapport Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Aeon Biopharma, Inc.、Protagenic Therapeutics, Inc.、Windtree Therapeutics, Inc.较为活跃,换手率分别为1327.56%、1257.46%、1219.64%,振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Plus Therapeutics, Inc.,振幅分别为122.48%、68.89%、68.09%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。Avalo 的产品线还包括 quisovalimab和 AVTX-008。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042339989bfcc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042339989bfcc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516308986","title":"Avalo Therapeutics, Inc.盘中异动 早盘股价大跌5.61%报6.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516308986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516308986?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:12","pubTimestamp":1741014730,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时12分,Avalo Therapeutics, Inc.股票出现异动,股价大幅跳水5.61%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。其相关个股中,Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为1475.56%、131.29%、106.66%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.,振幅分别为177.97%、70.53%、48.34%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231210a25d4c4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231210a25d4c4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","AVTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514320141","title":"Avalo Therapeutics, Inc.盘中异动 早盘股价大涨5.61%报6.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514320141?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753086,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分,Avalo Therapeutics, Inc.股票出现波动,股价快速上涨5.61%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Anaptysbio, Inc.、Enveric Biosciences, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃,换手率分别为480.36%、239.12%、55.70%,振幅较大的相关个股有Trevi Therapeutics, Inc.、Enanta Pharmaceuticals, Inc.、Aardvark Therapeutics, Inc.,振幅分别为7.11%、6.58%、6.22%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223126abe0ea2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223126abe0ea2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514861570","title":"Avalo Therapeutics, Inc.盘中异动 快速跳水5.10%报6.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514861570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514861570?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:11","pubTimestamp":1740597074,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时11分,Avalo Therapeutics, Inc.股票出现波动,股价快速跳水5.10%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.60%。其相关个股中,Enveric Biosciences, Inc.、Renovaro Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大,Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃,换手率分别为6533.97%、289.89%、257.10%,振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Organovo Holdings, Inc.,振幅分别为194.07%、81.11%、52.76%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227031114abde2a1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227031114abde2a1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514090328","title":"Avalo Therapeutics, Inc.盘中异动 急速下挫6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514090328?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:32","pubTimestamp":1740493959,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时32分,Avalo Therapeutics, Inc.股票出现异动,股价大幅跳水6.17%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。其相关个股中,Moleculin Biotech, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc涨幅较大,Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为751.75%、467.59%、235.58%,振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Maze Therapeutics, Inc.,振幅分别为20.51%、14.67%、8.87%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。Avalo 的产品线还包括 quisovalimab和 AVTX-008。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223239962ff292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223239962ff292&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513722414","title":"Avalo Therapeutics, Inc.盘中异动 早盘股价大涨6.04%报8.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513722414?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:36","pubTimestamp":1740407798,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时36分,Avalo Therapeutics, Inc.股票出现波动,股价快速上涨6.04%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.23%。其相关个股中,Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Aditxt, Inc.、Pepgen Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为43.71%、38.00%、24.48%,振幅较大的相关个股有Pepgen Inc.、Gossamer Bio, Inc.、Summit Therapeutics Inc.,振幅分别为70.07%、14.69%、14.51%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223638a252159c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223638a252159c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513296862","title":"Avalo Therapeutics, Inc.股价上涨10.82% 市值涨901.49万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513296862?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148296,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分,Avalo Therapeutics, Inc.股票出现异动,股价快速拉升10.82%。截至发稿,该股报7.94美元/股,成交量2338股,换手率0.02%,振幅0.63%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223136abd7af79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223136abd7af79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511614925","title":"Avalo Therapeutics, Inc.盘中异动 下午盘快速跳水5.30%报7.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511614925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511614925?lang=zh_cn&edition=full","pubTime":"2025-02-15 03:47","pubTimestamp":1739562464,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日03时47分,Avalo Therapeutics, Inc.股票出现异动,股价大幅下跌5.30%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。其相关个股中,Moleculin Biotech, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Allogene Therapeutics, Inc.涨幅较大,Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为3118.38%、794.65%、623.17%,振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ,振幅分别为74.35%、71.65%、66.45%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150347449885cf96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150347449885cf96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509466751","title":"Avalo Therapeutics, Inc.盘中异动 早盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509466751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509466751?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:15","pubTimestamp":1738685724,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时15分,Avalo Therapeutics, Inc.股票出现波动,股价急速拉升5.36%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.33%。其相关个股中,Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Evaxion Biotech As涨幅较大,Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为1628.85%、925.15%、449.97%,振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd,振幅分别为72.82%、49.88%、47.29%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。Avalo 的产品线还包括 quisovalimab和 AVTX-008。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001524abc23c8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001524abc23c8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508714122","title":"Avalo Therapeutics, Inc.盘中异动 快速下跌6.24%报7.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508714122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508714122?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:51","pubTimestamp":1738594293,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时51分,Avalo Therapeutics, Inc.股票出现波动,股价急速下跌6.24%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.42%。其相关个股中,Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大,Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃,换手率分别为430.00%、364.05%、232.46%,振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp.,振幅分别为97.05%、50.76%、36.85%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322513398797290&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322513398797290&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","AVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507620688","title":"Avalo Therapeutics, Inc.盘中异动 急速拉升5.79%报8.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507620688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507620688?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:50","pubTimestamp":1738252202,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时50分,Avalo Therapeutics, Inc.股票出现异动,股价快速拉升5.79%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.23%。其相关个股中,Tectonic Therapeutic, Inc.、Cero Therapeutics Holdings, Inc.、Kazia Therapeutics Limited涨幅较大,Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃,换手率分别为1565.36%、198.84%、194.86%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 ,振幅分别为61.86%、61.86%、56.41%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235002abbd5aa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235002abbd5aa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVTX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507543285","title":"Avalo Therapeutics, Inc.盘中异动 股价大涨7.82%报7.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507543285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507543285?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:36","pubTimestamp":1738082177,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时36分,Avalo Therapeutics, Inc.股票出现异动,股价大幅上涨7.82%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Silexion Therapeutics Corp、Transcode Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大,Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为4376.87%、3334.29%、2454.34%,振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Transcode Therapeutics, Inc.,振幅分别为176.95%、122.16%、102.05%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012900361796130253&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012900361796130253&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506308448","title":"Avalo Therapeutics, Inc.盘中异动 快速上涨5.52%报7.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506308448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506308448?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:33","pubTimestamp":1737988436,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时33分,Avalo Therapeutics, Inc.股票出现波动,股价快速拉升5.52%。Avalo Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。其相关个股中,Akero Therapeutics, Inc.、89Bio, Inc.、Onconetix, Inc.涨幅较大,Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃,换手率分别为730.99%、44.39%、40.37%,振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Evaxion Biotech As,振幅分别为53.75%、28.15%、18.91%。Avalo Therapeutics, Inc.公司简介:Avalo Therapeutics Inc 是一家临床阶段生物技术公司,专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223356a2316b98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223356a2316b98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avalotx.com","stockEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.3673},{"period":"3month","weight":-0.6564},{"period":"6month","weight":-0.5705},{"period":"1year","weight":-0.5775},{"period":"ytd","weight":-0.6074}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0404},{"period":"3month","weight":-0.0476},{"period":"6month","weight":-0.0138},{"period":"1year","weight":0.1003},{"period":"ytd","weight":0.0741}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Avalo Therapeutics, Inc.于2011年1月31日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,完全致力于开发基于IL-1β的免疫介导的炎症性疾病治疗方法。公司的主要候选产品abdakibart(AVTX-009),一种抗IL-1β单抗(“MAB”),正处于化脓性汗腺炎(“HS”)的2期临床试验中。该公司还在探索更多机会,以在存在大量未满足需求的流行适应症方面产生影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.063135},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.010519},{"month":3,"riseRate":0.272727,"avgChangeRate":0.280205},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.088879},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.046144},{"month":6,"riseRate":0.727273,"avgChangeRate":0.024954},{"month":7,"riseRate":0.454545,"avgChangeRate":0.02164},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.026031},{"month":9,"riseRate":0.545455,"avgChangeRate":0.023005},{"month":10,"riseRate":0.545455,"avgChangeRate":0.0983},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.046714},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.047903}],"exchange":"NASDAQ","name":"Avalo Therapeutics Inc","nameEN":"Avalo Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avalo Therapeutics Inc(AVTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Avalo Therapeutics Inc(AVTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Avalo Therapeutics Inc,AVTX,Avalo Therapeutics Inc股票,Avalo Therapeutics Inc股票老虎,Avalo Therapeutics Inc股票老虎国际,Avalo Therapeutics Inc行情,Avalo Therapeutics Inc股票行情,Avalo Therapeutics Inc股价,Avalo Therapeutics Inc股市,Avalo Therapeutics Inc股票价格,Avalo Therapeutics Inc股票交易,Avalo Therapeutics Inc股票购买,Avalo Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avalo Therapeutics Inc(AVTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Avalo Therapeutics Inc(AVTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}